Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Globalization and Health
Published in: Globalization and Health 1/2018

Open Access 01-12-2018 | Review

Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin

Authors: Simón Barquera, Dean Schillinger, Carlos A. Aguilar-Salinas, Marc Schenker, Luis A. Rodríguez, Cesar Hernández-Alcaraz, Jaime Sepúlveda-Amor, Mexico-California Diabetes collaborative group

Published in: Globalization and Health | Issue 1/2018

Login to get access

Abstract

Background

Type 2 Diabetes (T2D) is now a massive epidemic in both California and Mexico, with serious consequences for social and economic well-being. A large proportion of these populations share common ethnic backgrounds. Yet diverse environmental and social conditions across regions create unique opportunities to explore the ways that T2D risk, incidence, management and outcomes manifest.

Main Text

An action-oriented research consortium headed up by the University of California and Universidad Nacional Autónoma de Mexico was constituted to set priorities for bi-national translational research, in an attempt to implement and evaluate clinical, public health and policy actions to decrease the burden of T2D for people of Mexican origin. In this paper, we describe the epidemiology of T2D in Mexico and California, review current efforts to combat the epidemic, highlight gaps in knowledge and identify urgent areas of opportunity for collaboration.
The group has developed a common research agenda and funding has been obtained to evaluate biological samples from the 2016 Mexican Health Survey, collaborate in a telemedicine-based retinopathy project, implement interventions in food banks, promote a communications campaign, and design a large-scale diabetes prevention effectiveness trial.

Conclusions

T2D has caused a state of emergency in Mexico and is a major health problem among Mexican populations on both sides of the border. Understanding the commonalities and differences between California and Mexico for those of Mexican origin with respect to T2D, when combined with a sharing of knowledge and advances, can produce a bi-national translational research agenda to inform relevant policy and practice. Amidst economic and political uncertainty and limited healthcare budgets, this collaboration can contribute to the development of scientific evidence to inform policies and interventions. This may provide a promising collaborative model that could be expanded to other health conditions and regions of the world.
Literature
1.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.CrossRef
2.
Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. Jama. 2015;314:1021–9.CrossRefPubMed
3.
Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud publica de Mexico. 2010;52(Suppl 1):S72–9.PubMed
4.
5.
Barquera S, Pedroza-Tobias A, Medina C. Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double-burden of disease. Curr Opin Lipidol. 2016;27:329–44.
6.
Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386–402.
7.
Rull JA, Aguilar-Salinas CA, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res. 2005;36:188–96.CrossRefPubMed
8.
Barquera S, Campos I, Rivera JA. Mexico attempts to tackle obesity: the process, results, push backs and future challenges. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2013;14(Suppl 2):69–78.CrossRef
9.
Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr. 2002;5:113–22.CrossRefPubMed
10.
González-Pier E, Barraza-Lloréns M, Beyeler N, Jamison D, Knaul F, Lozano R, et al. Mexico’s path towards the sustainable development goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. Lancet Glob Health. 2016;4:e714–25.CrossRefPubMedPubMedCentral
11.
Villalpando S, Rojas R, Shamah-Levy T, Ávila MA, Gaona B, De la Cruz V, Rebollar R, Hernández L. Prevalence and distribution of type 2 Diabetes mellitus in Mexican adult population. A probabilistic survey. Salud publica Mex. 2010;52(Suppl 1):S19–S26.
12.
Hernandez Avila M, G J, Reynoso-Noveron N. Diabetes mellitus en Mexico. El estado de la epidemia. Salud publica de Mexico. 2013;55:S129–36.CrossRefPubMed
13.
Barquera S, Tolentino ML, Aguilar-Salinas C, Lopez-Ridaura R. The Mexico City Diabetes Mellitus Representative Survey. Cities Changing Diabetes Program. Cuernavaca Mor: Instituto Nacional de Salud Publica; 2015.
14.
Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS. Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and nutrition examination survey 1999-2004. Ann Epidemiol. 2008;18:222–9.CrossRefPubMed
15.
Harris SB, Ekoe JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract. 2005;70:90–7.CrossRefPubMed
16.
Alberti K, Zimmet P, Shaw J. The metabolic syndrome a new worldwide definition. Lancet. 2005;366:1059–62.PubMed
17.
Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, Shamah-Levy T, Rauda J, Avila-Burgos L, et al. Metabolic syndrome in Mexican adults: results from the National Health and nutrition survey 2006. Salud publica de Mexico. 2010;52(Suppl 1):S11–8.CrossRefPubMed
18.
Babey SH, Wolstein J, Diamant AL, Goldstein H. Prediabetes in California: nearly half of California adults on path to diabetes. UCLA Center for Health Policy Research. 2016;(PB2016-1):1-8
19.
Schillinger D, Jacobson MF. Science and public health on trial: warning notices on advertisements for sugary drinks. Jama. 2016;316(15):1545-1546.
20.
Fernandez A, Schillinger D, Warton EM, Adler N, Moffet HH, Schenker Y, et al. Language barriers, physician-patient language concordance, and glycemic control among insured Latinos with diabetes: the diabetes study of northern California (DISTANCE). J Gen Intern Med. 2011;26:170–6.CrossRefPubMed
21.
Centers for Disease Control and Prevention (CDC). National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. U.S. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
22.
Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 005–2006. Diabetes Care. 2009;32:287–94.CrossRefPubMedPubMedCentral
23.
Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. Jama. 2003;290:1884–90.CrossRefPubMed
24.
Alegre-Diaz J, Herrington W, Lopez-Cervantes M, Gnatiuc L, Ramirez R, Hill M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961–71.CrossRefPubMedPubMedCentral
25.
Secretaría de Salud. Acuerdo Nacional para la Salud Alimentaria: estrategia contra el sobrepeso y la obesidad. Mexico DF: Sub-Secretaría de Prevención y Promoción de la Salud de la Secretaría de Salud; 2010.
26.
Secretaría de Salud. Programa de Acción en el contexto escolar. Lineamientos técnicos para el expendio o distribución de alimentos y bebidas en los establecimientos de educación básica, vol. 2010; 2010.
27.
Rivera JA, Muñoz-Hernández O, Rosas-Peralta M, Aguilar-Salinas CA, Popkin BM, Willett WC. Consumo de bebidas para una vida saludable: recomendaciones para la población mexicana. Salud publica de Mexico. 2008;50:173–95.CrossRefPubMed
28.
29.
Theodore FL, Tolentino-Mayo L, Hernandez-Zenil E, Bahena L, Velasco A, Popkin B, et al. Pitfalls of the self-regulation of advertisements directed at children on Mexican television. Pediatr Obes. 2017;12(4):312–19. https://​doi.​org/​10.​1111/​ijpo.​12144. Epub 2016 May 2.
30.
31.
Academia Nacional de Medicina. Obesidad en México: recomendaciones para una política de estado. Ciudad de Mexico: UNAM; 2012.
32.
Aguilar-Salinas CA, Hernandez-Jimenez S, Hernández-Avila M, Hernández-Avila JE. Acciones para enfrentar a la diabetes. Documento de postura de la Academia Nacional de Medicina. Mexico: Intersistemas; 2015.
33.
Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-Avila M, et al. Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention. Salud publica de Mexico. 2008;50:419–27.CrossRefPubMed
34.
Blanco-Cornejo M, Castillo R, Riva-Palacio I, Cerritos A, Tena C, Sanchez I. El programa MIDE, un modelo exitoso del ISSSTE. In: Aguilar-Salinas CA, Hernandez-Jimenez S, Hernandez-Avila M, Hernandez-Avila JE, editors. Acciones para enfrentar a la diabetes. Mexico: Documento de postura de la Academia Nacional de Medicina. Intersistemas; 2015. p. 291–305.
35.
Hernandez-Jimenez S, Garcia-Ulloa C, Mehta R, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D. Innovative models for the empowerment of patients with type 2 diabetes: the CAIPaDi program. Recent patents on endocrine, metabolic & immune drug discovery. 2014;8:202–9.CrossRef
36.
37.
Bartlett S, Burstein N, Hamilton W. Food stamp program access study. Washington: Department of Agriculture, Economic Research Service; 2004.
38.
39.
40.
Seligman HK, Schillinger D. Hunger and socioeconomic disparities in chronic disease. N Engl J Med. 2010;363, 6
41.
42.
43.
Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S: the National Diabetes Prevention Program. Am J Prev Med. 2013;44:S346–51.CrossRefPubMedPubMedCentral
44.
45.
46.
47.
Guerrero AD, Chung PJ. Racial and ethnic disparities in dietary intake among California children. J Acad Nutr Diet. 2016;116(3):439–48.CrossRefPubMed
48.
Babey, S.H., Jones, M., Yu, H. and Goldstein, H., 2009. Bubbling over: soda consumption and its link to obesity in California.
49.
Sánchez-Pimienta TG, Batis C, Lutter CK, Rivera JA. Sugar-sweetened beverages are the main sources of added sugar intake in the Mexican population–5. J Nutr. 2016;146(9):1888S–96S.CrossRefPubMed
50.
51.
52.
Falbe J, Thompson HR, Becker CM, Rojas N, McCulloch CE, Madsen KA. Impact of the Berkeley excise tax on sugar-sweetened beverage consumption. Am J Public Health. 2016;106:1865–71.CrossRefPubMedPubMedCentral
53.
Rogers EA, Fine S, Handley MA, Davis H, Kass J, Schillinger D. Development and early implementation of the bigger picture, a youth-targeted public health literacy campaign to prevent type 2 diabetes. J Health Commun. 2014;19(Suppl 2):144–60.CrossRefPubMedPubMedCentral
54.
Rogers EA, Fine SC, Handley MA, Davis HB, Kass J, Schillinger D. Engaging minority youth in diabetes prevention efforts through a participatory, spoken-word social marketing campaign. American journal of health promotion : AJHP. 2016;
55.
56.
Gilmer TP, Philis-Tsimikas A, Walker C. Outcomes of project Dulce: a culturally specific diabetes management program. Ann Pharmacother. 2005;39:817–22.CrossRefPubMed
57.
Schillinger D, Handley M, Wang F, Hammer H. Effects of self-management support on structure, process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial. Diabetes Care. 2009;32:559–66.CrossRefPubMedPubMedCentral
58.
Schneiderman N, Llabre M, Cowie CC, Barnhart J, Carnethon M, Gallo LC, et al. Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic community health study/study of Latinos (HCHS/SOL). Diabetes Care. 2014;37:2233–9.CrossRefPubMedPubMedCentral
59.
Seligman HK, Lyles C, Marshall MB, Prendergast K, Smith MC, Headings A, et al. A pilot food Bank intervention featuring diabetes-appropriate food improved glycemic control among clients in three states. Health Aff (Millwood). 2015;34:1956–63.CrossRef
60.
Tieu L, Sarkar U, Schillinger D, Ralston JD, Ratanawongsa N, Pasick R, et al. Barriers and facilitators to online portal use among patients and caregivers in a safety net health care system: a qualitative study. J Med Internet Res. 2015;17:e275.CrossRefPubMedPubMedCentral
61.
Ward JB, Haan MN, Garcia ME, Lee A, To TM, Aiello AE. Intergenerational education mobility and depressive symptoms in a population of Mexican origin. Ann Epidemiol. 2016;26:461–6.CrossRefPubMedPubMedCentral
62.
Martínez-Cortés G, Salazar-Flores J, Fernández-Rodríguez LG, Rubi-Castellanos R, Rodríguez-Loya C, Velarde-Félix JS, Muñoz-Valle JF, Parra-Rojas I, Rangel-Villalobos H. Admixture and population structure in Mexican-mestizos based on paternal lineages. J Hum Genet. 2012;57(9):568–74. https://​doi.​org/​10.​1038/​jhg.​2012.​67.CrossRefPubMed
63.
64.
65.
Schillinger D, Tran J, Mangurian C, Kearns C. Do sugar-sweetened beverages cause obesity and diabetes? Industry and the manufacture of scientific controversy. Ann Intern Med. 2016;165:895–7.CrossRefPubMedPubMedCentral
66.
Schillinger D, Kearns C. Guidelines to limit added sugar intake: junk science or junk food? Ann Intern Med. 2016;166(4):305–6.CrossRefPubMed
67.
Metadata
Title
Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin
Authors
Simón Barquera
Dean Schillinger
Carlos A. Aguilar-Salinas
Marc Schenker
Luis A. Rodríguez
Cesar Hernández-Alcaraz
Jaime Sepúlveda-Amor
Mexico-California Diabetes collaborative group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2018
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-018-0390-5

Other articles of this Issue 1/2018

Globalization and Health 1/2018 Go to the issue

Review

Evaluation and learning in complex, rapidly changing health systems: China’s management of health sector reform

Research

The bumpy trajectory of performance-based financing for healthcare in Sierra Leone: agency, structure and frames shaping the policy process

Research

Securitizing HIV/AIDS: a game changer in state-societal relations in China?

Research

Sex differences and risk factors for diabetes mellitus - an international study from 193 countries

Debate

Ukrainian health care system and its chances for successful transition from Soviet legacies

Research

Global supermarkets’ corporate social responsibility commitments to public health: a content analysis